No connection

Search Results

Analysis Neutral

Mineralys Therapeutics' CEO Sold Shares Worth $1.97 Million. Should Investors Avoid the Stock?

Apr 07, 2026 15:30 UTC

Key PointsCEO Jon Congleton sold 75,000 shares for a total transaction value of ~$1.97 million on April 2, 2026..

  • April 07, 2026 — 11:30 am EDT Written byRobert IzquierdoforThe Motley Fool-> CEO Jon Congleton sold 75,000 shares for a total transaction value of ~$1
  • 97 million on April 2, 2026
  • The sale represented 9

April 07, 2026 — 11:30 am EDT Written byRobert IzquierdoforThe Motley Fool-> CEO Jon Congleton sold 75,000 shares for a total transaction value of ~$1.97 million on April 2, 2026. The sale represented 9.61% of direct holdings prior to the transaction, reducing direct ownership to 705,051 shares. All shares sold were directly held; no indirect entities or derivative securities were involved in this transaction. Trade size exceeded both recent and historical medians, reflecting a higher disposition cadence as direct share capacity declined. Jon Congleton, Chief Executive Officer ofMineralys Ther

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile